# US 2023/0273218 A1 · Kit for quantitative detection using fluorescent microarray

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0273218 A1
- Document ID: US20230273218A1
- Status: Published application
- Kind: A1
- Application number: 18/027,240
- Filed: 2021-06-10
- Published: 2023-08-31
- Earliest claimed: 2021-04-16
- Assignees: Hangzhou Zheda Dixun Biological Gene Engineering Co., Ltd.
- Applicants: Hangzhou Zheda Dixun Biological Gene Engineering Co., Ltd.
- Inventors: Zhoujie WU; Yi LIU; Shandong WU; Huahao SHEN; Shanshan CHEN; Shaochang WU; Yifei WANG; Mingzhi ZHU; Meijie WANG; Chuhan CHEN
- Web page: https://patentgrep.com/patent/US20230273218A1

## CPC

- G01N 33/6854: {Immunoglobulins}
- G01N 33/6863: {Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors}
- B01L 3/50855: {using modular assemblies of strips or of individual wells}
- G01N 33/54387: {Immunochromatographic test strips}
- G01N 33/545: Synthetic resin
- G01N 33/577: involving monoclonal antibodies {binding reaction mechanisms characterised by the use of monoclonal antibodies (G01N33/5302 - G01N33/576 take precedence)}
- G01N 33/582: {with fluorescent label}
- G01N 33/587: {Nanoparticles}
- G01N 33/6866: {Interferon}
- G01N 33/6869: {Interleukin}
- B01L 2200/16: Reagents, handling or storing thereof
- G01N 33/54353: {with ligand attached to the carrier via a chemical coupling agent (coatings G01N33/54393)}
- G01N 2800/24: Immunology or allergic disorders
- G01N 2800/60: Complex ways of combining multiple protein biomarkers for diagnosis
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present disclosure relates to a kit for quantitative detection using a fluorescent microarray, and belongs to the technical field of protein detection. The kit of the present disclosure includes a detection plate and a detection antibody coupled with fluorescent microspheres, where the detection plate is provided with a plurality of reaction chambers; the reaction chamber is provided with an opening, and an inner bottom surface of the reaction chamber is provided with a plurality of detection sites that are arranged side by side along a length direction of the reaction chamber at an interval. The kit of the present disclosure may detect allergen-specific IgE, IgG and IgA with high sensitivity, as well as rapidly and quantitatively detect an allergen-specific antibody IgE, IgG and IgA concentration in human serum or plasma, and may screen dozens of allergens at a time.

## Claims

### Claim at position 1

1-12. (canceled)

### Claim 13

A kit for quantitatively detecting cytokine or allergen-specific IgE, IgG comprising IgG4, and IgA using a fluorescent microarray, the kit comprising a detection plate and a detection antibody coupled with fluorescent microspheres, wherein the detection plate is provided with a plurality of reaction chambers; the reaction chamber is provided with an opening, and an inner bottom surface of the reaction chamber is provided with a plurality of detection sites that are arranged side by side along a length direction of the reaction chamber at an interval;
an analyte comprises a cytokine or allergen-specific IgE, IgG comprising IgG4, and IgA;
a material of the detection plate comprises polystyrene (PS); an upper end of the reaction chamber is provided with an opening; an inner bottom surface of the reaction chamber is provided with a plurality of detection sites that are arranged side by side along a length direction of the reaction chamber at an interval and the detection site is a groove or a raised column;
when the analyte of the kit is a cytokine, the detection sites of the detection plate are fixed with test-cytokine-specific monoclonal antibodies and the detection antibody coupled with fluorescent microspheres is a paired antibody of the test cytokine coupled with fluorescent microspheres; the test cytokine is selected from the group consisting of IL-1beta, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12P70, IL-17A, TNF-α, IFN-γ, and IFN-α;
a preparation method of the detection plate with detection sites fixed with the test-cytokine-specific monoclonal antibodies comprises the following steps:
coating each detection site of the detection plate with streptavidin to obtain a coated detection plate; labeling the test-cytokine-specific monoclonal antibody with biotin to obtain a biotin-labeled test-cytokine-specific monoclonal antibody; and coupling the biotin-labeled test-cytokine-specific monoclonal antibodies to different detection sites of the detection plate respectively to obtain the detection plate fixed with the test-cytokine-specific monoclonal antibodies.
a preparation method of the detection plate fixed with the test-cytokine-specific monoclonal antibodies comprises the following steps:
coating each detection site of the detection plate with streptavidin to obtain a coated detection plate; labeling the test-cytokine-specific monoclonal antibody with biotin to obtain a biotin-labeled test-cytokine-specific monoclonal antibody; and coupling the biotin-labeled test-cytokine-specific monoclonal antibodies to different detection sites of the detection plate respectively to obtain the detection plate fixed with the test-cytokine-specific monoclonal antibodies.
when the analyte is allergen-specific IgE, IgG comprising IgG4, or IgA, the detection sites of the detection plate are fixed with test allergens, and the detection antibody coupled with microspheres is an anti-human IgE, IgG comprising IgG4, or IgA antibody coupled with fluorescent microspheres; the test allergen is selected from the group consisting of mite allergens, plant pollen allergens, mold allergens, animal dander allergens, insect allergens, plant food allergens, animal food allergens, and drug allergens;
a preparation method of the detection plate fixed with the test allergens comprises the following steps:
coating each detection site of the detection plate with streptavidin to obtain a coated detection plate; labeling a test allergen with biotin to obtain a biotin-labeled test allergen; and
coupling the biotin-labeled test allergens to different detection sites of the detection plate respectively to obtain the detection plate fixed with the test allergens.

### Claim 14 (depends on 13)

The kit according to claim 13, wherein the detection plate has 5-20 reaction chambers and each reaction chamber provides 20-50 detection sites.

### Claim 15 (depends on 13)

The kit according to claim 13, wherein the test-cytokine-specific monoclonal antibody, before being labeled with biotin, is dissolved in 0.01M PBS buffer with a pH of 7.4;
the paired antibody of the test cytokine, before being coupled with fluorescent microspheres, is dissolved in 0.01M PBS buffer with a pH of 7.4 containing 0.05% by mass Tween 20, 0.05% by mass Proclin-300, and 0.1% by mass BSA.

### Claim 16 (depends on 13)

The kit according to claim 13, wherein the test-cytokine-specific allergen, before being labeled with biotin, is dissolved in 0.1M PBS buffer with a pH of 7.4;
the test allergen, before being coupled with fluorescent microspheres, is dissolved in 0.01M PBS buffer with a pH of 7.4 containing 0.05% by mass Tween 20, 0.05% by mass Proclin-300, and 0.1% by mass BSA.
